COVID-19 in a Cohort of Patients with Congenital Myasthenic Syndrome.
J Neuromuscul Dis
; 8(6): 1003-1005, 2021.
Article
en En
| MEDLINE
| ID: mdl-34120913
ABSTRACT
Congenital Myasthenic Syndromes (CMS) are a rare group of genetic disorders of neuromuscular transmission. Some subtypes of CMS can be associated with respiratory and bulbar weakness and these patients may therefore be at high risk of developing a severe disease from COVID-19. We screened 73 patients with genetically confirmed CMS who were attending the UK national referral centre for evidence of previous Severe Acute Respiratory Syndrome Corona Virus 2 infection and their clinical outcome. Of 73 patients, seven had history of confirmed COVID-19. None of the infected patients developed a severe disease, and there were no signals that CMS alone carries a high risk of severe disease from COVID-19.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Síndromes Miasténicos Congénitos
/
COVID-19
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Neuromuscul Dis
Año:
2021
Tipo del documento:
Article